Endo Pharmaceuticals To Announce Third Quarter 2014 Financial Results On November 5, 2014

DUBLIN, Oct. 20, 2014 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its third quarter 2014 financial results before the open of the U.S. financial markets on November 5, 2014 and members of its senior management team will host a conference call and webcast at 9:00 a.m. ET that day.

The dial-in number to access the call is U.S./Canada (866) 318-8616, International (617) 399-5135, and the passcode is 87960776. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from November 5, 2014 at 12:30 p.m. ET until 11:59 p.m. ET on November 12, 2014 by dialing (888)-286-8010 (U.S./Canada) or (617)-801-6888 (International) and entering the passcode 40905841.

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 11:59 p.m. ET on November 12, 2014. The replay can be accessed by clicking on “Events” in the Investor Relations section of the website.

About Endo International plc
Endo International plc is a global specialty healthcare company focused on improving patients’ lives while creating shareholder value. Endo develops, manufactures, markets, and distributes quality branded pharmaceutical, generic and device products through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-announce-third-quarter-2014-financial-results-on-november-5-2014-751645343.html

SOURCE Endo International plc

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC